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α7 Nicotinic Acetylcholine Receptor Signaling Inhibits
Inflammasome Activation by Preventing Mitochondrial DNA
Release
Ben Lu,1,2 Kevin Kwan,2 Yaakov A Levine,2,3 Peder S Olofsson,2 Huan Yang,2 Jianhua Li,2 Sonia Joshi,2
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The mammalian immune system and the nervous system coevolved under the influence of cellular and environmental stress.
Cellular stress is associated with changes in immunity and activation of the NACHT, LRR and PYD domains-containing protein 3
(NLRP3) inflammasome, a key component of innate immunity. Here we show that α7 nicotinic acetylcholine receptor (α7 nAchR)signaling inhibits inflammasome activation and prevents release of mitochondrial DNA, an NLRP3 ligand. Cholinergic receptor agonists or vagus nerve stimulation significantly inhibits inflammasome activation, whereas genetic deletion of α7 nAchR significantly
enhances inflammasome activation. Acetylcholine accumulates in macrophage cytoplasm after adenosine triphosphate (ATP)
stimulation in an α7 nAchR-independent manner. Acetylcholine significantly attenuated calcium or hydrogen oxide–induced mitochondrial damage and mitochondrial DNA release. Together, these findings reveal a novel neurotransmitter-mediated signaling
pathway: acetylcholine translocates into the cytoplasm of immune cells during inflammation and inhibits NLRP3 inflammasome
activation by preventing mitochondrial DNA release.
Online address: http://www.molmed.org
doi: 10.2119/molmed.2013.00117

INTRODUCTION
Neural circuits control multiple organ
systems to fine-tune function and maintain homeostasis, which is crucial for
survival of multicellular organisms. During infection or tissue injury, detection of
the presence of pathogens or damaged
host cells activates the immune system to
initiate inflammatory responses. This
step is essential for combating invading

pathogens and promoting tissue repair.
Failure to resolve inflammation, however, contributes to tissue damage and
organ dysfunction. Nonresolving inflammation underlies the pathogenesis of
acute and chronic diseases, including
rheumatoid arthritis, atherosclerosis, cancer, obesity and insulin resistance (1).
Previously, we identified a neural circuit,
termed the “inflammatory reflex,” which
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regulates the function of the innate immune system (2,3). This prototypical regulatory pathway requires the vagus
nerve, splenic CD4+ T cells that relay
neural signals and produce acetylcholine,
and α7 nAchR expressed in splenic
macrophages and other cytokineproducing immune cells (4). Stimulation
of the vagus nerve increases acetylcholine levels in the spleen, prevents excessive proinflammatory cytokine production during endotoxemia and
experimental sepsis (4), and reduces disease severity in human rheumatoid
arthritis (5). A key unsolved question is
the molecular mechanism by which
cholinergic neural signals regulate inflammatory responses in immune cells.
Extracellular high-mobility group box
1 (HMGB1) released by activated immune cells or damaged tissue cells is a
cytokine-like mediator of inflammation
during sterile and infectious injury (6).
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Administration of neutralizing antiHMGB1 monoclonal antibody (mAb), or
HMGB1 antagonists, significantly reduce
the severity of experimental inflammatory disease, promotes bacterial clearance during Pseudomonas aeruginosa infection and prevents memory
impairment in sepsis survivors (6–9). The
molecular mechanism of HMGB1 release
by activated immune cells depends on
activation of inflammasomes. These are
multiprotein complexes that cleave
procaspase-1 to mediate the proteolytic
maturation of interleukin (IL)-1β and
IL-18, and pyroptosis, a form of proinflammatory programmed cell death
(10–16). Genetic deletion of inflammasome components or pharmacological inhibition of caspase activity inhibits
HMGB1 release (10–15).
We and others have previously established that vagus nerve stimulation or
cholinergic receptor agonists significantly inhibit HMGB1 release and prevent the systemic accumulation of
HMGB1 during inflammation (17,18).
Other findings indicate that the NACHT,
LRR and PYD domains-containing protein 3 (NLRP3) inflammasome mediates
HMGB1 release during endotoxemia or
bacteremia (10–12) and that cytosolic oxidized mitochondrial DNA activates the
NLRP3 inflammasome (19,20). Accordingly, here we postulated that cholinergic
agonists inhibit NLRP3 inflammasome
activation by preventing mitochondrial
DNA release.
MATERIALS AND METHODS
Reagents
Lipopolysaccharides (LPS; Escherichia
coli, 0111:B4), acetylcholine and adenosine
triphosphate (ATP) were purchased from
Sigma (Sigma-Aldrich, St. Louis, MO,
USA). Anti-mouse IL-1β (sc-1251), antimouse caspase-1 (sc-514) and anti-human
caspase-1 (sc-622) antibodies were from
Santa Cruz Biotechnology (Santa Cruz,
CA, USA). Mouse anti-HMGB1 mAb
IgG2b 2G7 (noncommercial antibody) is
originally from Critical Therapeutic (Boston, MA, USA), available upon request.

Plasmids expressing procaspase-1, ASC,
NLRP3 or α7 nAchR were purchased
from Origene (Rockville, MD, USA). Mitotracker green and Mitotracker deep red
were purchased from Invitrogen/Life
Technologies (Carlsbad, CA, USA). Mitochondrial isolation and purification kits
were from Qiagen (Germantown, MD,
USA). Choline/acetylcholine assay kits
were from Abcam (Cambridge, MA,
USA). Murine macrophage colonystimulating factor (GM-CSF) and human
macrophage colony-stimulating factor
(M-CSF) were purchased from Peprotech
(Rocky Hill, NJ, USA).
Mice and Vagus Nerve Stimulation
Mice deficient for the α7 nicotinic receptor (C57BL/6 background) and WT
littermates were purchased from The
Jackson Laboratory (Bar Harbor, ME,
USA; B6.129S7-Chrna7tm1Bay, number
003232). Mice were housed at 25°C on a
12-h light/dark cycle and acclimatized
for at least 1 wk before conducting experiments. For vagus nerve stimulation,
mice were anesthetized with ketamine
(100 mg/kg intraperitoneally [IP]) and
xylazine (10 mg/kg IP). A midline cervical incision was made and the left cervical vagus nerve was isolated and placed
on a bipolar platinum electrode (Plastics
One, Roanoke, VA, USA). Electrical stimulation was delivered at 1 V, 2 ms and
5 Hz for 2.5 min by a stimulation module
(STM100A) controlled by the AcqKnowledge software (Biopac Systems, Aero
Camino Goleta, CA, USA). Three hours
after vagus nerve stimulation, endotoxin
(LPS from Escherichia coli, 0111:B4; SigmaAldrich) was injected (10 mg/kg IP).
Mice were euthanized 2.5 h later and
serum was obtained for determination of
IL-1β, IL-18 and IL-6 concentration by
enzyme-linked immunosorbent assay
(ELISA). Vagus nerve studies were acute,
nonsurvival procedures where the animal remained anesthetized the entire period. All experiments were performed
under protocols approved by the Institutional Animal Care and Use Committee
of the Feinstein Institute for Medical Research, North Shore-LIJ Health System.

Cell Isolation and Culture
Peritoneal mouse macrophages. Peritoneal mouse macrophages were isolated
as described previously (15). Briefly, mice
were injected intraperitoneally with 4%
of sterile thioglycollate solution 3–5 d before macrophage isolation. Mice were euthanized with CO2 and were then injected intraperitoneally with 11.6% of
sterile sucrose solution. Peritoneal lavage
was collected and filtered through a cell
strainer with a pore size of 40 μm. Cells
were spinned down at 400g for 15 min.
The cell pellets were then resuspended in
macrophage culture medium (RPMI medium 1640 supplemented with 10% fetal
bovine serum, 100 U/mL penicillin and
100 μg/mL streptomycin).
Bone marrow–derived dendritic cells.
Bone marrow–derived dendritic cells
(BMDCs) were generated in vitro from
bone marrow cells from 6- to 8-wk-old
mice as previously described (15). Briefly,
femurs and tibias were flushed with
RPMI-1640 to release the bone marrow
cells in RPMI-1640 supplemented with
10% heat-inactivated fetal calf serum,
100 mg/mL penicillin, 100 mg/mL streptomycin and 5 × 10–5 mol/L mercaptoethanol (20 ng/mL murine GM-CSF).
On d 3, the supernatants were gently removed and replaced with the same volume of media. On d 6, the nonadherent
cells were collected.
Human macrophages. Primary blood
mononuclear cells were isolated by
density-gradient centrifugation. Then
cells were collected and cultured in
RPMI 1640 medium with 10% heatinactivated human serum. After 2 h incubation at 37°C, adherent cells were
detached with 10 mmol/L ethylenediaminetetraacetic acid (EDTA), and then
resuspended (106 cells/mL) in medium
supplemented with human macrophage
colony-stimulating factor (20 ng/mL)
and cultured for 7 d.
Cell stimulation. The 106 peritoneal
mouse macrophages or M-CSF–
differentiated human macrophages plated
in 12-well plates were primed with ultrapure LPS (500 ng/mL) for 4 h and then
pulsed with ATP (5 mmol/L) for 30 min.
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ELISA
Levels of IL-1β, IL-18 and IL-6 in the
culture medium or mouse serum samples were determined using quantitative
ELISA kits (R&D Systems, Minneapolis,
MN, USA) with reference to standard
curves of purified recombinant proteins
at various dilutions.
Western Blot Analysis
Proteins from cell-free supernatants
were extracted by methanol/chloroform
precipitation as described previously
(15). Briefly, cell culture supernatants
were precipitated by the addition of an
equal volume of methanol and 0.25 volumes of chloroform and then were vortexed and centrifuged for 10 min at
20,000g. The upper phase was discarded
and 500 μL methanol was added to the
interphase. This mixture was centrifuged
for 10 min at 20,000g, and the protein
pellet was dried at 55°C, resuspended in
Laemmli buffer and boiled for 5 min at
99°C. Cell extracts were prepared as described previously. Samples were separated by 4–20% sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(PAGE) or 4–20% native PAGE and were
transferred onto polyvinylidene fluoride
membranes.
Reconstituted Inflammasome in
HEK293A Cells
For the human NLRP3 inflammasome
reconstitution assays, 0.2 × 106 HEK293A
cells were seeded onto 24-well plates in
cell culture media lacking antibiotics.
Then, 24 h later, cells were transfected
with plasmids expressing pro-IL-1β and
inflammasome components (Origene),
such as ASC, procaspase-1 and NLRP3
by using lipofectamine 2000. These modified cells were then cotransfected with
either plasmids that express α7 nAchR or
empty plasmids (Origene). The total
amount of DNA was standardized to
600 ng per well by using a control plasmid. The transfection efficiency was
monitored by using a GFP-encoding
plasmid and fluorescent microscopy, and
the transfection rate was observed to be
around 70%. Cell lysates were harvested

24 h later and analyzed for caspase-1
cleavage by Western blot analysis. Nontransfected HEK293A cells do not express detectable procaspase-1. Caspase-1
activation was standardized by levels of
procaspase-1 in cell lysates of transfected
HEK293A cells.
Acetylcholine Assay
Mouse peritoneal macrophages were
primed with LPS for 3 h. And cells were
stimulated with ATP (2.5 mmol/L) in the
presence or absence of extracellular
acetylcholine (1 mmol/L) for the indicated time. Then cells were washed two
times with precooled 1× phosphatebuffered saline (PBS) to get rid of extracellular acetylcholine. Cell lysates were
obtained, and total choline and acetylcholine levels were assessed by using a
choline/acetylcholine assay kit (Abcam).
Flow Cytometry Analysis
Mitochondrial perturbation was assessed by flow cytometry as described
previously (23,24) with some modifications. Briefly, BMDCs were primed with
LPS (200 ng/mL) in 15-mL tubes for 2 h
and then stained with Mitotracker green
and Mitotracker deep red at 100 nmol/L
for 30 min at 37°C. The nonadherent cells
were collected and stimulated by ATP
(1 mmol/L) for 15 min. Cells were
quickly transferred on ice for fluorescence-activated cell sorter analysis.
Mitochondrial DNA Release Assay
The mtDNA levels in cytosol were measured as described previously (20). Briefly,
1 × 107 peritoneal macrophages were homogenized with a dounce homogenizer in
the presence of protease inhibitor and
then were subjected to centrifugation at
700g for 10 min at 4°C. Protein concentration and volume of the supernatant were
normalized, followed by centrifugation at
10,000g for 30 min at 4°C for the production of a supernatant corresponding to the
cytosolic fraction. DNA was isolated from
200 μL of the cytosolic fraction by using a
DNeasy Blood & Tissue kit (Qiagen).
In the cell-free system, purified mitochondria were stimulated with CaCl2 or
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H2O2 (0.5 mmol/L) as described previously (23). Briefly, the purified mitochondria (120 mg protein per mL) were incubated with either 200 μmol/L CaCl2 or
0.5 mmol/L H2O2 in the presence or absence of different doses of acetylcholine
for 15 min at room temperature and were
immediately pelleted by centrifugation
(10 min, 7,000g) at 4°C. DNA was isolated
from 200 μL mitochondrial supernatant
by using a DNeasy Blood & Tissue kit.
The levels of mtDNA encoding cytochrome c oxidase 1 were measured by
quantitative real-time PCR with the same
volume of the DNA solution. The following primers were used: mouse cychrome c
oxidase I forward, 5′-GCCCCAGATA
TAGCATTCCC-3′, and reverse, 5′-GTTCA
TCCTGTTCCTGCTCC-3′.
Statistical Analysis
Data are expressed as mean ± standard
deviation (SD) of at least three independent experiments (n = 3–5). One-way
analysis of variance and Student t test
were used for comparison among all different groups. A p value <0.05 was considered statistically significant.
All supplementary materials are available
online at www.molmed.org.
RESULTS
Cholinergic Agonists Inhibit
Inflammasome Activation
To test the hypothesis that cholinergic
neural signals inhibit NLRP3 inflammasome activation, LPS-primed mouse peritoneal macrophages were stimulated
with ATP in the presence or the absence
of different concentrations of acetylcholine. Acetylcholine exposure dosedependently inhibited ATP-induced activation of caspase-1, cleavage of pro-IL-1β
and HMGB1 release (Figure 1A). Addition of acetylcholine failed to inhibit the
expression of pro-IL-1β in the cell lysates
(Figure 1A), indicating that inhibition of
IL-1β production by acetylcholine is due
to the suppression of inflammasome activity, rather than LPS-induced priming.
Next, inflammasome activation was as-
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Figure 1. Cholinergic neural signals inhibit inflammasome activation. LPS-primed peritoneal mouse macrophages (A) or human macrophages (B) were stimulated with ATP in the presence or the absence of different dose of acetylcholine (Ach) for 30 min. (C) Mice were
subjected to vagus nerve stimulation (VNS) or sham operation. At 3 h later, all mice were injected intraperitoneally with LPS (10 mg/kg).
And serum samples were collected 2.5 h later. (D) LPS-primed peritoneal mouse macrophages were stimulated with ATP in the presence
or the absence of different dose of GTS-21 for 15 min. (D) Mice were injected intraperitoneally with LPS (10 mg/kg) alone or LPS (10 mg/kg)
and GTS-21 (4 mg/kg). And serum samples were collected 2.5 h later. IL-1β cleavage, HMGB1 release and caspase-1 activation were assessed by Western blot analysis. Levels of IL-1β, IL-18 or IL-6 in cell culture medium or serum samples were measured by ELISA. Blots are
representative of three independent experiments. Data shown are means ± SD. #p < 0.05 versus nonstimulated or sham-operated groups.

sessed in human macrophages exposed
to acetylcholine. Human macrophages
did not secrete detectable amounts of
IL-1β after LPS stimulation (Figure 1B).
However, ATP subsequent stimulation of
LPS-primed human macrophages rapidly
induced IL-1β secretion, which was dose-

dependently inhibited by acetylcholine.
In contrast, addition of acetylcholine
failed to attenuate LPS-induced IL-6 production, which does not depend on inflammasome activation (Figure 1B). To investigate whether cholinergic neural
signals inhibit inflammasome activation

in vivo, mice were subjected to vagus
nerve stimulation or sham operation.
Three hours later, the animals were challenged with lethal doses of LPS. We observed that vagus nerve stimulation significantly reduced serum levels of IL-1β
and IL-18, as compared with that of sham
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operation (Figure 1C); IL-6 was not inhibited by vagus nerve stimulation (Figure
1C). Finally, inflammasome activity was
assessed in LPS-primed mouse peritoneal
macrophage–activated ATP in the presence or absence of GTS-21, an α7 nAchR
agonist. GTS-21 dose-dependently inhibited ATP-induced IL-1β cleavage (Figure
1D). Together, these observations indicate
that cholinergic agonists inhibit inflammasome activation in vitro and in vivo.
α7 nAchR Signaling Inhibits the NLRP3
Inflammasome Activation
The major target of GTS-21 is α7 nAchR,
which is expressed in macrophages and
dendritic cells (21). Together with our
previous findings that α7 nAchR is an
important regulator of inflammation
and an essential component of the inflammatory reflex (22), we reasoned that
cholinergic agonists might inhibit the
NLRP3 inflammasome activation
through interaction with α7 nAchR. To
test this hypothesis, we challenged both
α7 nAchR knockout (α7 KO) mice and
wild-type (WT) controls with a lethal
dose of LPS. Notably, the serum levels of
IL-1β and IL-18 were significantly higher
in α7 KO compared with that of WT
mice (Figure 2A). The production of IL-6,
however, was not significantly altered in
α7 KO mice (Figure 2A). Genetic deletion
of α7 nAchR also significantly increased
IL-1β cleavage in peritoneal mouse
macrophages in vitro (Figure 2B). These
results indicate that α7 nAchR negatively
regulates inflammasome activation.
To further investigate the role of α7
nAchR in NLRP3 inflammasome activation, we reconstituted the functional
NLRP3 inflammasome in nonimmune
HEK293A cells by transfection of these
cells with plasmids that encode inflammasome components NLRP3, ASC and
procaspase-1 (15). Western blot analysis
reveals that expression of these inflammasome components in HEK293A cells
induces cleavage of procaspase-1; this is
indicative of a functional inflammasome
(Figure 2C). Coexpression of α7 nAchR
in these genetically modified cells significantly inhibited the cleavage of

Figure 2. α7 nAchR negatively regulates inflammasome activation. (A) LPS-primed peritoneal mouse macrophages from either WT or α7 nAchR knockout (a7 KO) mice were
stimulated with ATP in the presence or the absence of acetylcholine for 30 min. (B) WT
and a7 KO mice were injected intraperitoneally with LPS (10 mg/kg). Serum samples were
collected 2.5 h later. (C) HEK293A cells were transfected with plasmids as indicated. At
24 h after transfection, cell lysates were harvested. IL-1β cleavage and caspase-1 activation were assessed by Western blot analysis. Serum levels of IL-1β, IL-18 or IL-6 were measured by ELISA. Blots are representative of three independent experiments. Data shown
are means ± SD.

procaspase-1. Addition of a selective
α7 nAchR agonist (PNU-28879) further
decreased activation of caspase-1 (Figure 2C). Collectively, these findings establish that α7 nAchR signaling inhibits
NLRP3 inflammasome activation.
α7 nAchR Signaling Attenuates ATPInduced Mitochondrial Perturbation
Prior work implicated mitochondrial
perturbation in NLRP3 inflammasome
activation (23). ATP stimulation mobilizes
Ca2+ from the endoplasmic reticulum or
extracellular space to the cytoplasm, and
the resultant increase in mitochondrial
permeability has been linked to the
NLRP3 inflammasome activation (24). α7
nAchR is expressed in the mitochondrial
outer membrane in nonneuronal cells, including monocytes, B lymphocytes and
hepatocytes (25,26). To confirm that α7
nAchR is localized in mitochondria, we
transfected HEK293 cells with Myctagged α7 nAchR and then stained the
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genetically modified cells with the antiMyc antibodies and a mitochondrial
marker. Indeed, we observed the localization of Myc-tagged α7 nAchR in mitochondria (Supplementary Figure S1). We
next hypothesized that α7 nAchR signaling attenuates ATP-induced mitochondrial perturbation. To test this, we incubated primary BMDCs with MitoTrack
green and MitoTrack deep red to stain
total mitochondria and mitochondria
with normal membrane potential, respectively. Consistent with previous studies,
LPS and ATP stimulation resulted in robust increase of cells that had lost mitoTrack deep red staining, indicative of mitochondrial perturbation in these cells
(Figure 3). Genetic deletion of α7 nAchR
significantly enhanced ATP-induced mitochondrial perturbation in LPS-prime
BMDCs (Figure 3A). Further, acetylcholine
dose-dependently inhibited ATP-induced
mitochondrial perturbation in WT, but not
in α7 nAchR knockout (a7 KO), BMDCs
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Figure 3. Cholinergic neural signals attenuate ATP-induced mitochondrial perturbation. (A,C) LPS-primed mouse BMDCs from WT or a7 KO
mice were stimulated by ATP. (B,D) LPS-primed mouse BMDCs from WT mice were stimulated by ATP in the presence or the absence of
absence of acetylcholine. (C) LPS-primed mouse BMDCs from WT mice were stimulated by ATP in the presence or the absence of
acetylcholine. Mitochondrial perturbation was assessed by flow cytometry analysis by using Mitotracker green and Mitotracker deep red.
Upper panels (A,B) show the representative graph; lower panels (C–E) show means ± SD. #p < 0.05 versus ATP-stimulated alone.

(Figures 3B–E), indicating that α7 nAchR
signaling attenuates ATP-induced mitochondrial perturbation.
Acetylcholine Accumulates in
Cytoplasm upon ATP Stimulation
Although it is known that acetylcholine
and other α7 nAchR agonists abolish Ca2+
or hydrogen oxide–induced cytochrome c
release from isolated mitochondria (25),
the mechanism for extracellular acetylcholine translocation into cytoplasm has
remained unknown. One possibility is
that extracellular acetylcholine accumu-

lates in the cytoplasm of immune cells
upon ATP stimulation. To test this, LPSprimed mouse peritoneal macrophages
were stimulated with ATP in the presence
of extracellular acetylcholine (1 mmol/L),
and acetylcholine levels in cell lysates
were subsequently measured. We observed that ATP stimulation induced increased acetylcholine levels in the cell
lysates (Figure 4A), indicating that extracellular acetylcholine accumulates in cytoplasm on ATP stimulation. This process
does not depend on α7 nAchR, because
genetic deletion of α7 nAchR did not

block ATP-induced acetylcholine accumulation in the cell lysates (Figure 4B).
Previous studies show that ATP stimulation could result in the formation of pannexin pores that increase permeability of
cytoplasmic membrane to small molecules (<900 Da) (27). To determine
whether pannexin is involved in ATPinduced acetylcholine accumulation in
cell lysates, mouse macrophages were
stimulated with ATP in the presence of
Panx-10, a peptide that is reported to
block the pannexin pores (27), or a control peptide. Notably, addition of Panx-10
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Figure 4. Acetylcholine translocates into cytoplasm upon ATP stimulation. (A) LPS-primed peritoneal mouse macrophages from WT mice
were stimulated by ATP for an indicated time. (B) LPS-primed peritoneal mouse macrophages from WT or a7 KO mice were stimulated by
ATP for an indicated time. (C) LPS-primed peritoneal mouse macrophages from WT mice were stimulated by ATP in the presence of an indicated dose of 10 Panx or scramble peptides. Intracellular acetylcholine (Ach) levels were assessed using a choline/acetylcholine assay kit.

did not significantly inhibit ATP-induced
acetylcholine accumulation in cell lysates,
as compared with that of control peptide
(Figure 4C). Collectively, these results
demonstrated that acetylcholine rapidly
accumulates in the cytoplasm of immune
cells on ATP stimulation in an α7 nAchRand pannexin-independent manner.
α7 nAchR Signaling Prevents
Mitochondrial DNA Release
Early studies indicate that mitochondrial DNA release into cytoplasm is associated with NLRP3 inflammasome activation (19,20). Oxidized mitochondrial
DNA molecules function as NLRP3 ligands that induce the assembly and activation of the NLRP3 inflammasome (19).
Accordingly, we reasoned that α7 nAchR
signaling prevents mitochondrial DNA
release into cytoplasm. Mouse macrophages were stimulated with ATP in the
presence of different concentrations of
acetylcholine. Then the cytoplasmic fraction was extracted, and mitochondrial
DNA levels were assessed by using
quantitative polymerase chain reaction
(qPCR) with primers for the cytochrome c
oxidase 1 gene. Indeed, acetylcholine
dose-dependently inhibited ATP-induced
mitochondrial DNA release into cytoplasm in WT macrophages (Figure 5A).
However, acetylcholine did not significantly inhibit ATP-induced mitochondrial
DNA release into cytoplasm in α7 nAchR

Figure 5. Acetylcholine prevents mitochondrial DNA (mtDNA) release. LPS-primed peritoneal mouse macrophages from either WT (A) or a7 KO (B) mice were stimulated with
ATP in the presence or the absence of acetylcholine for 15 min. DNA was isolated from
the cytosolic fraction of macrophages. And then the levels of mtDNA were measured by
quantitative real-time PCR. Purified mitochondria were incubated with either 200 μmol/L
CaCl2 (C) or 0.5 mmol/L H2O2 (D) in the presence or absence of different dose of acetylcholine for 15 min and were immediately pelleted by centrifugation. Levels of mtDNA in
the mitochondria-free supernatant were measured by quantitative real-time PCR. Data
shown are means ± SD. #p < 0.05 versus stimulated groups.
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Figure 6. The mechanisms by which acetylcholine inhibits inflammasome activation. Extracellular ATP activates the NLRP3 inflammasome by provoking intracellular potassium efflux
and mitochondrial DNA release into cytoplasm. Stimulation of ATP also results in rapid influx of acetylcholine into cytoplasm. There, acetylcholine prevents mitochondrial DNA release through α7 nAchR and subsequently inhibits the NLRP3 inflammasome activation.

knockout (α7 KO) macrophages, even at
the higher concentration (Figure 5B).
These data indicate that acetylcholine
inhibits ATP-induced mitochondrial
DNA release into cytoplasm in an
α7 nAchR-dependent manner. Further,
we asked whether acetylcholine could
inhibit mitochondrial DNA release in
isolated mitochondria in a cell-free system. Macrophage mitochondria were
isolated and then challenged with Ca2+
or hydrogen oxide in the presence of
different doses of acetylcholine. Mitochondrial DNA levels in supernatant
were measured by qPCR. Addition of
acetylcholine significantly inhibited Ca2+
or hydrogen oxide–induced mitochondrial DNA release (Figures 5C, D).
Mitophagy is a selective form of autophagy by which injured mitochondria
are degraded into auto-lysosomes. Recent studies have shown that activation
of autophagy/mitophagy by inflammatory signals limits IL-1β production (20).

To study the role of α7 nAchR signaling
in regulation of autophagy, LPS-primed
mouse macrophages were stimulated
with ATP in the presence of different
concentration of acetylcholine for
20 min. Exposure to acetylcholine did
not alter the cellular levels of LC3B-II
(Supplementary Figure S2), suggesting
that α7 nAchR signaling prevents mitochondrial DNA release in an autophagyindependent manner.
DISCUSSION
These findings establish an important
mechanism of mitochondrial α7 nAchR
signaling in regulation of the NLRP3 inflammasome activation that reduces mitochondrial DNA release. Inflammasomes are intracellular protein
complexes that mediate maturation of
IL-1β and IL-18 and execute the process
of proinflammatory programmed cell
death (termed “pyroptosis”). Unlike
other types of inflammasomes, the

NLRP3 inflammasome can be triggered
by a broad range of endogenous and exogenous danger signals (28). Instead of
binding NLRP3 directly, these stimuli activate the NLRP3 inflammasome by provoking intracellular potassium efflux and
mitochondrial DNA release into cytoplasm (19,29). In this study, we found
that stimulation of ATP results in a rapid
influx of acetylcholine into the cytoplasm, enabling intracellular acetylcholine to interact with mitochondrial α7
nAchR and in turn prevent mitochondrial DNA release (Figure 6). Because oxidized mitochondrial DNA molecules
bind and activate the NLRP3 inflammasome (19), our findings provide a mechanism for acetylcholine inhibition of ATPinduced NLRP3 inflammasome
activation by preventing mitochondrial
DNA release into cytoplasm. It is noteworthy that other NLRP3 inflammasome
agonists, such as nigericin and adjuvant
aluminum, have also been implicated in
inducing the influx of acetylcholine into
the cytoplasm through formation of
pores in the cytoplasmic membrane and
after lysosomal damage, respectively.
The inflammasome-dependent cytokines IL-1β, IL-18 and HMGB1 orchestrate the inflammatory responses to infection and sterile tissue injury. However,
deregulated production of these cytokines drives the pathogenesis of many
inheritable or acquired diseases and disorders, such as obesity, type 2 diabetes,
atherosclerosis, arthritis, colitis and sepsis (30). Interestingly, cholinergic neural
signals also inhibit the production of inflammasome-independent cytokines, including tumor necrosis factor (31). This
study reveals a novel pathway through
which cholinergic agonists may modulate target cells by activating intracellular
cholinergic receptors on mitochrondria.
Although emerging evidence shows that
many nonneuron cells (such as monocytes, B lymphocytes and hepatocytes)
contain intracellular pools of nicotinic
cholinergic receptors, the biological function of these intracellular cholinergic receptors had previously been elusive
(25,26).
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CONCLUSION
Here we show that ATP stimulation induces rapid influx of acetylcholine into
cytoplasm, where the acetylcholine can
engage mitochondrial cholinergic receptors. Importantly, we and others show
that these intracellular nicotinic cholinergic receptors (especially the α7 nAchR)
are biologically functional. Addition of
acetylcholine or other α7 nAchR agonists, such as choline, markedly inhibits
Ca2+ or hydrogen oxide–induced mitochondrial DNA or cytochrome C release
in isolated mitochondria from macrophages or hepatocytes, respectively.
These findings suggest two antiinflammatory drug targets: mitochondrial
membrane receptors and plasma membrane acetylcholine transporters that regulate mitochondrial homeostasis and inflammasome activity.
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